Filtered By:
Condition: Atrial Fibrillation
Therapy: Corticosteroid Therapy

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 19 results found since Jan 2013.

Percutaneous Left Atrial Appendage Closure in a Patient with Diffuse Alveolar Hemorrhaging Associated with Anticoagulant Therapy and Atrial Fibrillation: A Case Report
Intern Med. 2021 Nov 27. doi: 10.2169/internalmedicine.8551-21. Online ahead of print.ABSTRACTDiffuse alveolar hemorrhaging (DAH) due to oral anticoagulation (OAC) is a life-threatening condition that leads to severe respiratory failure. There is a clinical dilemma in that OAC-induced DAH often forces the discontinuation of OAC therapy and the administration of high-dose corticosteroids, which increases the risk of stroke and cardiovascular events. We herein report the first case of OAC-induced DAH and atrial fibrillation (AF) in a patient who completely discontinued OAC therapy and high-dose corticosteroids after experien...
Source: Internal Medicine - November 29, 2021 Category: Internal Medicine Authors: Takaaki Ogoshi Masato Fukunaga Yu Suzuki Yusuke Taura Kazuhiro Yatera Source Type: research

Retrospective cohort study investigating synergism of air pollution and corticosteroid exposure in promoting cardiovascular and thromboembolic events in older adults
Conclusion PM2.5 and systemic corticosteroid use were independently associated with increases in CTE hospitalisations. We also found evidence of significant additive interactions between the two exposures for HF and MI/ACSs suggesting synergy between these two exposures.
Source: BMJ Open - September 13, 2023 Category: General Medicine Authors: Josey, K., Nethery, R., Visaria, A., Bates, B., Gandhi, P., Parthasarathi, A., Rua, M., Robinson, D., Setoguchi, S. Tags: Open access, Epidemiology Source Type: research